LJPC logo

La Jolla Pharmaceutical (LJPC) Accounts Payable

Annual Accounts Payable

$2.28 M
-$484.00 K-17.52%

December 31, 2021

Summary

Performance

1-Year Change

-17.52%

3-Year Change

-73.43%

5-Year Change

-80.16%

15-Year Change

-80.16%

LJPC Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$11.48 M
LJPC annual accounts payable is currently -80.16% below its historical high of $11.48 million

3-Year Low

$2.28 M
LJPC annual accounts payable is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
LJPC previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
LJPC next annual earnings announcement has not yet been scheduled

OtherLJPCbalance sheetmetrics:

Annual Accounts Receivable

$8.61 M
LJPC annual accounts receivable is $8.61 million

Annual Total Liabilities

$167.97 M
LJPC annual total liabilities is $167.97 million

Annual Total Assets

$101.23 M
LJPC annual total assets is $101.23 million

Annual Current Assets

$67.31 M
LJPC annual total current assets is $67.31 million

Quarterly Accounts Payable

$2.13 M
-$664.00 K-23.81%

June 30, 2022

Summary

Performance

3-Month Change

-23.81%

1-Year Change

+15.11%

3-Year Change

-56.7%

5-Year Change

-64.1%

LJPC Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$11.48 M
LJPC quarterly accounts payable is currently -81.50% below its historical high of $11.48 million

3-Year Low

$2.13 M
LJPC quarterly accounts payable is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
LJPC previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
LJPC next earnings announcement has not yet been scheduled

OtherLJPCbalance sheetmetrics:

Quarterly Accounts Receivable

$5.93 M
LJPC quarterly accounts receivable is $5.93 million

Quarterly Total Liabilities

$168.83 M
LJPC quarterly total liabilities is $168.83 million

Quarterly Total Assets

$99.37 M
LJPC quarterly total assets is $99.37 million

Quarterly Current Assets

$66.36 M
LJPC quarterly total current assets is $66.36 million

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

LJPC Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-17.5%+15.1%
3 y3 years-73.4%-56.7%
5 y5 years-80.2%-64.1%

LJPC Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat low-23.8%at low
5 y5-year-45.5%at low-49.1%-48.3%
alltimeall time-80.2%-99.6%-81.5%-99.6%

La Jolla Pharmaceutical Accounts Payable History

DateAnnualQuarterly
Jun 2022
-
$2.13 M(-23.8%)
Mar 2022
-
$2.79 M(+22.4%)
Dec 2021
$2.28 M(-17.5%)
$2.28 M(-1.6%)
Sep 2021
-
$2.31 M(+25.4%)
Jun 2021
-
$1.85 M(+68.1%)
Mar 2021
-
$1.10 M(-60.2%)
Dec 2020
$2.76 M(-33.9%)
$2.76 M(-29.7%)
Sep 2020
-
$3.93 M(+58.3%)
Jun 2020
-
$2.48 M(+30.9%)
Mar 2020
-
$1.90 M(-54.6%)
Dec 2019
$4.18 M(-51.3%)
$4.18 M(-21.7%)
Sep 2019
-
$5.34 M(+8.8%)
Jun 2019
-
$4.91 M(+61.4%)
Mar 2019
-
$3.04 M(-64.5%)
Dec 2018
$8.57 M(-25.4%)
$8.57 M(+30.5%)
Sep 2018
-
$6.57 M(+8.3%)
Jun 2018
-
$6.07 M(-17.1%)
Mar 2018
-
$7.32 M(-36.3%)
Dec 2017
$11.48 M(+72.6%)
$11.48 M(+84.1%)
Sep 2017
-
$6.24 M(+5.4%)
Jun 2017
-
$5.92 M(+41.9%)
Mar 2017
-
$4.17 M(-37.3%)
Dec 2016
$6.65 M(+118.0%)
$6.65 M(+232.9%)
Sep 2016
-
$2.00 M(-11.4%)
Jun 2016
-
$2.26 M(-6.3%)
Mar 2016
-
$2.41 M(-21.1%)
Dec 2015
$3.05 M(+318.1%)
$3.05 M(+18.9%)
Sep 2015
-
$2.57 M(+39.3%)
Jun 2015
-
$1.84 M(-25.1%)
Mar 2015
-
$2.46 M(+236.8%)
Dec 2014
$730.00 K(-12.5%)
$730.00 K(+6.9%)
Sep 2014
-
$683.00 K(-25.5%)
Jun 2014
-
$917.00 K(+63.2%)
Mar 2014
-
$562.00 K(-32.6%)
Dec 2013
$834.00 K(+806.5%)
$834.00 K(+76.3%)
Sep 2013
-
$473.00 K(+168.8%)
Jun 2013
-
$176.00 K(+155.1%)
Mar 2013
-
$69.00 K(-25.0%)
Dec 2012
$92.00 K(+1050.0%)
$92.00 K(+35.3%)
Sep 2012
-
$68.00 K(-47.3%)
Jun 2012
-
$129.00 K(+258.3%)
Mar 2012
-
$36.00 K(+350.0%)
Dec 2011
$8000.00(-79.5%)
$8000.00(-65.2%)
Sep 2011
-
$23.00 K(-11.5%)
Jun 2011
-
$26.00 K(-3.7%)
Mar 2011
-
$27.00 K(-30.8%)
Dec 2010
$39.00 K(-68.8%)
$39.00 K(+77.3%)
Sep 2010
-
$22.00 K(-74.7%)
Jun 2010
-
$87.00 K(+3.6%)
Mar 2010
-
$84.00 K(-32.8%)
Dec 2009
$125.00 K(-97.3%)
$125.00 K(-81.9%)
Sep 2009
-
$692.00 K(-75.2%)
Jun 2009
-
$2.79 M(-71.4%)
Mar 2009
-
$9.77 M(+111.2%)
Dec 2008
$4.63 M
$4.63 M(+17.6%)
Sep 2008
-
$3.93 M(+80.1%)
Jun 2008
-
$2.18 M(-29.0%)
DateAnnualQuarterly
Mar 2008
-
$3.08 M(+39.7%)
Dec 2007
$2.20 M(+3.7%)
$2.20 M(+18.1%)
Sep 2007
-
$1.87 M(+67.2%)
Jun 2007
-
$1.12 M(-56.8%)
Mar 2007
-
$2.58 M(+21.5%)
Dec 2006
$2.13 M(+145.4%)
$2.13 M(+31.6%)
Sep 2006
-
$1.61 M(+39.7%)
Jun 2006
-
$1.16 M(-6.5%)
Mar 2006
-
$1.24 M(+42.7%)
Dec 2005
$866.00 K(-40.5%)
$866.00 K(+77.1%)
Sep 2005
-
$489.00 K(-24.4%)
Jun 2005
-
$647.00 K(+4.7%)
Mar 2005
-
$618.00 K(-57.5%)
Dec 2004
$1.46 M(+423.4%)
$1.46 M(-52.7%)
Sep 2004
-
$3.08 M(+220.6%)
Jun 2004
-
$960.00 K(-33.9%)
Mar 2004
-
$1.45 M(+422.7%)
Dec 2003
$278.00 K(-84.9%)
$278.00 K(-41.0%)
Sep 2003
-
$471.00 K(-52.8%)
Jun 2003
-
$998.00 K(-72.2%)
Mar 2003
-
$3.58 M(+94.1%)
Dec 2002
$1.85 M(+148.5%)
$1.85 M(+7.6%)
Sep 2002
-
$1.72 M(+80.3%)
Jun 2002
-
$952.00 K(+7.3%)
Mar 2002
-
$887.00 K(+19.4%)
Dec 2001
$743.00 K(+58.8%)
$743.00 K(+25.1%)
Sep 2001
-
$594.00 K(-4.2%)
Jun 2001
-
$620.00 K(-22.6%)
Mar 2001
-
$801.00 K(+71.2%)
Dec 2000
$468.00 K(+108.0%)
$468.00 K(+50.5%)
Sep 2000
-
$311.00 K(+48.1%)
Jun 2000
-
$210.00 K(-25.5%)
Mar 2000
-
$282.00 K(+25.3%)
Dec 1999
$225.00 K(-82.7%)
$225.00 K(+125.0%)
Sep 1999
-
$100.00 K(-50.0%)
Jun 1999
-
$200.00 K(-33.3%)
Mar 1999
-
$300.00 K(-76.9%)
Dec 1998
$1.30 M(0.0%)
$1.30 M(+333.3%)
Sep 1998
-
$300.00 K(-25.0%)
Jun 1998
-
$400.00 K(-20.0%)
Mar 1998
-
$500.00 K(-61.5%)
Dec 1997
$1.30 M(-13.3%)
$1.30 M(+225.0%)
Sep 1997
-
$400.00 K(+33.3%)
Jun 1997
-
$300.00 K(-50.0%)
Mar 1997
-
$600.00 K(-60.0%)
Dec 1996
$1.50 M(+114.3%)
$1.50 M(+87.5%)
Sep 1996
-
$800.00 K(-11.1%)
Jun 1996
-
$900.00 K(+28.6%)
Mar 1996
-
$700.00 K(0.0%)
Dec 1995
$700.00 K(+16.7%)
$700.00 K(-22.2%)
Sep 1995
-
$900.00 K(+125.0%)
Jun 1995
-
$400.00 K(0.0%)
Mar 1995
-
$400.00 K(-33.3%)
Dec 1994
$600.00 K
$600.00 K(-14.3%)
Sep 1994
-
$700.00 K(0.0%)
Jun 1994
-
$700.00 K(+40.0%)
Mar 1994
-
$500.00 K

FAQ

  • What is La Jolla Pharmaceutical annual accounts payable?
  • What is the all time high annual accounts payable for La Jolla Pharmaceutical?
  • What is La Jolla Pharmaceutical annual accounts payable year-on-year change?
  • What is La Jolla Pharmaceutical quarterly accounts payable?
  • What is the all time high quarterly accounts payable for La Jolla Pharmaceutical?
  • What is La Jolla Pharmaceutical quarterly accounts payable year-on-year change?

What is La Jolla Pharmaceutical annual accounts payable?

The current annual accounts payable of LJPC is $2.28 M

What is the all time high annual accounts payable for La Jolla Pharmaceutical?

La Jolla Pharmaceutical all-time high annual accounts payable is $11.48 M

What is La Jolla Pharmaceutical annual accounts payable year-on-year change?

Over the past year, LJPC annual accounts payable has changed by -$484.00 K (-17.52%)

What is La Jolla Pharmaceutical quarterly accounts payable?

The current quarterly accounts payable of LJPC is $2.13 M

What is the all time high quarterly accounts payable for La Jolla Pharmaceutical?

La Jolla Pharmaceutical all-time high quarterly accounts payable is $11.48 M

What is La Jolla Pharmaceutical quarterly accounts payable year-on-year change?

Over the past year, LJPC quarterly accounts payable has changed by +$279.00 K (+15.11%)